A narrative review of medical, chiropractic, and alternative health practices in the treatment of primary dysmenorrhea

Journal of Chiropractic Medicine

Volumn 4, Issue 2, 2005, Pages 76-88

  Spears, Lolita G ^a  

^a LOGAN COLLEGE OF CHIROPRACTIC   (United States)

Author keywords

Chiropractic; Complementary Therapies; Dysmenorrhea; Eastern Medicine; Manipulation, Spinal; Physical Therapy; Women's Health

Indexed keywords

EID: 77949552518     PISSN: 15563707     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-3467(07)60117-7     Document Type: Article

References (86)

1. Coco A.S. Primary dysmenorrhea. Am Fam Physician 60 (1999) 489-496
2. Fisher W.A., Dervaitis K.L., Bryan A.D., Silcox J., and Kohn H. Sexual health, reproductive health, sexual coercion, and partner abuse indicators in a Canadian obstetrics and gynaecology outpatient population. J SOGC 22 (2000) 714-724
3. Furnham A., and McGill C. Medical students' attitudes about complementary and alternative medicine. J Altern Complement Med 9 (2003) 275-284
4. Von Gruenigen V.E., White L.J., Kirven M.S., Showalter A.L., Hopskins M.P., and Jenison E.L. A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer 11 (2001) 205-209
5. Oki T., Douchi T., Maruta K., Nakamura S., and Nagata Y. Changes in endometrial wave-like movements in accordance with the phases of menstrual cycle. J Obststet Gynaecol Res 28 (2002) 176-181
6. De Ziegler D., Bulletti C., Fanchin R., Epiney M., and Brioscihi P.A. Contractility of the non pregnant uterus: the follicular phase. Ann N Y Acad Sci 943 (2001) 172-184
7. Nigam S., Benedetto C., Zonca M., Leo-Rossberg I., Lubbert H., and Hammerstein J. Increased concentrations of eicosanoids and plateletactivating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids 4 (1991) 137-141
8. Minuz P., Andrioli G., Degan M., Giano S., Ortolani R., Tommasoli R., et al. The F2-isoprostane 8epiprostaglandin F2alpha increases platelet adhesion and reduce the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol 18 (1998) 1248-1256
9. Adelantado J.M., Rees M.C., Lopez Bernal A., and Turnbull A.C. Increased uterine prostaglandin E receptors in menorrhagic women. Br J Obstet Gynaecol 95 (1998) 162-165
10. Abu J.I., and Konje J.C. Leukotrienes in gynaecology: the hypothetical value of anti-leukotriene therapy in dysmenorrhea and endometriosis. Hum Reprod Update 6 (2000) 200-205
11. Akerlund M. Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhea. Prog Brain Res 139 (2002) 359-365
12. Dmitrovic R. Tranvaginal color Doppler study of uterine blood flow in primary dysmenorrhea. Acta Obstet Gynecol Scand 79 (2000) 1112-1116
13. Wu D., Wang X., Chen D., Niu T., Ni J., Liu X., and Xu X. Metabolic gene polymorphisms and risk of dysmenorrhea. Epidemiology 11 (2000) 648-653
14. Mergler D., and Vezina N. Dysmenorrhea and cold exposure. J Reprod Med 30 (1985) 106-111
15. Messing K., Saurel-Cubizolles M.J., Bourgine M., and Kaminski M. Factors associated with dysmenorrhea among workers in French poultry slaughterhouses and canneries. J Occup Med 35 (1993) 493-500
16. Yang J.M., Chen Q.Y., and Jiang X.Z. Effects of metallic mercury on the perimenstrual symptoms and menstrual outcomes of exposed workers. Am J Ind Med 42 (2002) 403-409
17. Solomon G.M., and Schettler T. Endocrine disruption and potential human health implications. CMAJ 163 (2000) 1471-1476
18. Rama Sastry B.V., Hemonolor M.E., and Olenick M. Prostaglandin E2 in human placenta: its vascular effects and activation of prostaglandin E2 formation by nicotine and cotinine. Pharmacology 58 (1999) 70-86
19. Dejmek J., Solansky I., Podrazilova K., and Sram R.J. The exposure of nonsmoking and smoking mothers to environmental tobacco smoke during different gestations phases and fetal growth. Environ Health Perspect 110 (2002) 601-606
20. Chen C., Cho S.I., Damokosh A.I., Chen D., Li G., Wang X., and Xu X. Prospective study of exposure to environmental tobacco smoke and dysmenorrhea. Environ Health Perspect 108 (2000) 1019-1022
21. El-Defrawi M.H., Lotfy G., Dandash K.F., Refaat A.H., and Eyada M. Female genital mutilation and its psychosexual impact. J Sex Marital Ther 27 (2001) 465-473
22. Tassorelli C., Sandrini G., Cecchini A.P., Nappi R.E., Sances G., and Martignoni E. Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women. Psychosom Med 64 (2002) 621-626
23. Bajaj P., Bajaj P., Madsen H., and Arendt-Nielsen L. A comparison of modality-specific somatosensory changes during menstruation in dysmenorrheic and nondysmenorrheic women. Clin J Pain 18 (2002) 180-190
24. Larroy C. Comparing visual-analog and numeric scales for assessing menstrual pain. Behav Med 27 (2002) 179-181
25. Wyatt K.M., Dimmock P.W., Hayes-Gill B., Crowe J., and O'Brien P.M. Menstrual symptometrics: a simple computer-aided method to quantify menstrual cycle disorders. Fertil Steril 78 (2002) 96-101
26. Murphy A.A. Clinical aspects of endometriosis. Ann N Y Acad Sci 955 (2002) 1-10 34-6396-406
27. Bulletti C., de Ziegler D., Polli V., del Ferro E., Palini S., and Flamigni C. Characteristics of uterine contractility during menses in women with mild to moderate endometriosis. Fertil Steril 77 (2002) 1156-1161
28. th ed. (2001), Mosby, St. Louis 532-534 1085-6, 1217-58
29. Schroeder B., Sanfilippo J.S., and Hertweck S.P. Musculoskeletal pelvic pain in a pediatric and adolescent gynecology practice. J Pediatr Adolesc Gynecol 13 (2000) 90
30. nd ed. 1 (1999), Williams and Wilkins, Baltimore 943 952-3
31. Gatterman M.I. Chiropractic management of spine related disorders (1990), Lippincott Williams and Wilkins, Baltimore 285-329
32. Morris H. Surgical pathology of the lower uterine segment caesarean section scar: is the scar a source of clinical symptoms?. Int J Gynecol Pathol 14 (1995) 16-20
33. Little P., Everitt H., Williamson I., Warner G., Moore M., Gould C., et al. Preferences of patients for patient centred approach to consultation in primary care: observational study. BMJ 322 (2001) 468-472
34. Rutishauser C., Esslinger A., Bond L., and Sennhauser F.H. Consultations with adolescents: the gap between their expectations and their experiences. Acta Paediatr 92 (2003) 132-136
35. Bisaga K., Petkova E., Cheng J., Davies M., Feldman J.F., and Whitaker A.H. Menstrual functioning and psychopathology in a country-wide population of high school girls. J Am Acad Child Adolesc Psychiatry 41 (2002) 1197-1204
36. Maheux B., Haley N., Rivard M., and Gervais A. Do physicians assess lifestyle health risks during general medical examinations? A survey of general practitioners and obstetrician-gynecologists in Quebec. CMAJ 160 (1999) 1830-1834
37. Farley M., and Patsalides B.M. Physical symptoms, posttraumatic stress disorder, and healthcare utilization of women with and without childhood physical and sexual abuse. Psychol Rep 89 (2001) 595-606
38. Golding J.M., Wilsnack S.C., and Learman L.A. Prevalence of sexual assault history among women with common gynelogical symptoms. Am J Obstet Gynecol 179 (1998) 1013-1019
39. Lechner M.E., Vogel M.E., Gracia-Shelton L.M., Leichter J.L., and Steibel K.R. Self-reported medical problems of adult female survivors of childhood sexual abuse. J Fam Pract 36 (1993) 633-638
40. Booton D.A., and Seideman R.Y. Relationship between premenstrual syndrome and dysmenorrhea. AAOHN J 37 (1989) 308-315
41. Wilson C.A., and Keye Jr. W.R. A Survey of adolescent dysmenorrhea and premenstrual symptom frequency. A model program for prevention, detection, and treatment. J Adolesc Health Care 10 (1989) 317-322
42. Freeman E.W., Rickels K., and Sondheimer S.J. Premenstrual symptoms and dysmenorrhea in relation to emotional distress factors in adolescents. J Psychosom Obstet Gynaecol 14 (1993) 41-50
43. Hargrove J.T., and Abraham G.E. The incidence of premenstrual tension in a gynecologic clinic. J Reprod Med 27 (1982) 721-724
44. Freeman E.W., Rickels K., Schweizer E., and Ting T. Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms. Psychol Med 25 (1995) 309-315
45. Frackiewicz E.J., and Shiovitz T.M. Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder. J Am Pharm Assoc 41 (2001) 437-447
46. Palmero F., and Choliz M. Resting heart rate (HR) in women with and without premenstrual symptoms (PMS). J Behav Med 14 (1991) 125-139
47. Douglas S. Premenstrual syndrome. Evidence-based treatment in family practice. Can Fam Physician 48 (2002) 1789-1797
48. Walsh M.J., and Polus B.I. The frequency of positive common spinal clinical examination findings in a sample of premenstrual syndrome sufferers. J Manipulative Physiol Ther 22 (1999) 216-220
49. Walsh M.J., and Polus B.I. A randomized, placebo-controlled clinical trial on the efficacy of chiropractic therapy on premenstrual syndrome. J Manipulative Physiol Ther 22 (1999) 582-585
50. Wyatt K.M., Dimmock P.W., and O'Brien P.M. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 4 (2002) 1396
51. Pearlstein T. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?. Drugs 62 (2002) 1869-1885
52. Hernandez-Reif M., Martinez A., Field T., Quintero O., Hart S., and Burman I. Premenstrual symptoms are relieved by massage therapy. J Psychosom Obstet Gynaecol 21 (2000) 9-15
53. Montero P., Bernis C., Loukid M., Hilali K., and Baali A. Characteristics of menstrual cycles in Moroccan girls: prevalence of dysfunctions and associated behaviors. Ann Hum Biol 26 (1999) 243-249
54. Singh M.M., Devi R., and Gupta S.S. Awareness and health seeking behaviour of rural adolescent school girls on menstrual and reproductive health problems. Indian J Med Sci 53 (1999) 439-443
55. Demir S.C., Kadayyfey T.O., vardar M.A., and Atay Y. Dysfunctional uterine bleeding and other menstrual problems of secondary school students in Adana, Turkey. J Pediatr Adolesc Gynecol 13 (2000) 171-175
56. Harlow S.D., and Park M. A longitudinal study of risk factors for the occurrences, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynecol 103 (1996) 1134-1142
57. Adair L.S. Size at birth predicts age at menarche. Pediatrics 107 (2001) E59
58. Tahirovic H.F. Menarchal age and the stress of war: an example from Bosnia. Eur J Pediatr 157 (1998) 978-980
59. Kim K., and Smith P.K. Childhood stress, behavioural symptoms and motherdaughter pubertal devlopment. J Adolesc 21 (1998) 231-240
60. Comings D.E., Muhleman D., Johnson J.P., and MacMurray J.P. Parentdaughter transmission of the androgen receptor gene as an explanation of the effect of father absence on age of menarche. Child Dev 73 (2002) 1046-1051
61. Banikarim C., Chacko M.R., and Kelder S.H. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med 154 (2000) 1226-1229
62. Harlow B.L., Wise L.A., Otto M.W., Soares C.N., and Cohen L.S. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 60 (2003) 29-36
63. Avis N.E., Crawford S.L., and McKinlay S.M. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 3 (1997) 103-120
64. Kingsberg S.A. The impact of aging on sexual function in women and their partners. Arch Sex Behav 31 (2002) 431-437
65. Kuller L.H. Women's Health Initiative. Hormone replacement therapy and risk of cardiovascular disease: implications of the results of the Woman's Health Initiative. Arterioscler Thromb Vasc Biol 23 (2003) 11-16
66. Oliver M.N., Sheufelt J., Deshpande P., Grandage K.K., St Anna L., and Hansen L. Which postmenopausal women should be offered combined HRT?. J Fam Pract 52 (2003) 149-150
67. Hahn R.G. Compliance considerations with estrogen replacement: withdrawal bleeding and their factors. Am J Obstet Gynecol 161 (1989) 1854-1858
68. Milsom I., Minic M., Dawood M.Y., Akin M.D., Spann J., Niland N.F., and Squire R.A. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies. Clin Ther 24 (2002) 1384-1400
69. Akin M.D., Weingand K.W., Hengehold D.A., Goodale M.B., Hinkle R.T., and Smith R.P. Continuous low-level topical heat in the treatment of dysmenorrhea. Obstet Gynecol 97 (2001) 343-349
70. Metheny W.P., and Smith R.P. The relationship among exercise, stress, and primary dysmenorrhea. J Behav Med 12 (1989) 569-586
71. Balbi C., Musone R., Menditto A., Di Priso L., Cassese E., D'Ajello M., et al. Influence of menstrual factors and dietary habits on menstrual pain in adolescence age. Eur J Obstet Gynecol Reprod Biol 91 (2000) 143-148
72. Anderson F.D., and Hait H. A multicenter, randomized study of an etended cycle oral contraceptive. Contraception 68 (2003) 89-96
73. Tantbirojn P., and Taneepananichskul S. Clinical comparitive study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg thinylestradiol/250 microg norgestimate in Thai women. Contraception 66 (2002) 401-405
74. Leyden J., Shalita A., Hordinsky M., swinyer L., Stanczyk F.Z., and Weber M.E. Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl Estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: a randomized, placebo-controlled trial. J Am Acad Dermatol 47 (2002) 399-409
75. Alsalameh S., Burian M., Mahr G., Woodcock B.G., and Geisslinger G. Review article: the pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor. Aliment Pharmacol Ther 17 (2003) 489-501
76. Lichten E.M., and Bombard J. Surgical treatment of primary dysmenorrhea with laparoscopic uterine nerve ablation. J Reprod Med 32 (1987) 37-41
77. Shergill S.K., Shergill H.K., Gupta M., and Kaur S. Clinicopathological study of hysterectomies. J Indian Med Assoc 100 (2002) 238-239 246
78. Morrissey K., Idriss N., Nieman L., Winkel C., and Stratton P. Dysmenorrhea after bilateral tubal ligation: a case of retrograde menstruation. Obstet Gynecol 100 (2002) 1065-1067
79. Kokjohn K., Schmid D.M., Triano J.J., and Brennan P.C. The effect of spinal manipulation on pain and prostaglandin laevels in women with primary dysmenorrhea. J Manipulative Physiol Ther 15 (1992) 279-285
80. Hondras M.A., Long C.R., and Brennan P.C. Spinal manipulative therapy versus a low force mimic maneuver for women with primary dysmenorrhea a randomized, observer-blinded, clinical trial. Pain 81 (1999) 105-114
81. Boesler D., Warner M., Alpers A., Finnerty E.P., and Kilmore M.A. Efficacy of high-velocity low-amplitude manipulative technique in subjects with low-back pain during menstrual cramping. J Am Osteopath Assoc 93 (1993) 203-208 213-4
82. Vance A.R., Hayes S.H., and Spielholz N.I. Microwave diathermy treatment for primary dysmenorrhea. Phys Ther 76 (1996) 1003-1008
83. Kaplan B., Rabinerson D., Lurie S., Peled Y., Royburt M., and Neri A. Clinical evaluation of a new model of a transcutaneous electrical nerve stimulation device for the management of primary dysmenorrhea. Gynecol Obstet Invest 44 (1997) 255-259
84. Pouresmail Z., and Ibrahimzadeh R. Effects of acupressure and ibuprofen on the severity of primary dysmenorrhea. J Tradit Chin Med 22 (2002) 205-210
85. Taylor D., Miaskowski C., and Kohn J. A randomized clinical trial of the effectiveness of an acupressure device (relief brief) for managing symptoms of dysmenorrhea. J Altern Complement Med 8 (2002) 357-370
86. Griffiths V. Traditional Chinese medicine: a case of dysmenorrhea. Aust J Holist Nurs 7 (2000) 42-43